Latest news with #CMU
The Herald Scotland
8 hours ago
- Sport
- The Herald Scotland
Central Michigan gets NCAA Notice of Allegations in Conor Stallions case
The database shows CMU involved in an investigation that began on Oct. 31, 2023, the same day as photos were posted online that appeared to show then-Michigan defensive analyst Connor Stalions on the Chippewas' sidelines for the school's season-opening game against Michigan State in 2023. The individual in the photos disguised his appearance with facial hair and was dressed similarly to members of the Central Michigan coaching staff. The person also wore sunglasses with a light in the corner, strongly suggesting the use of a recording device. Stalions didn't recall attending "a specific game there," he said during an interview for a recent Netflix documentary. "I don't even think this guy looks like me." In a statement provided last November in the wake of the documentary's release, Central Michigan said, "We are aware of inferences made in the new Netflix documentary regarding former University of Michigan football staff member Connor Stalions accessing the CMU sidelines during our opening game last September. For the past ten months, CMU has fully cooperated with the NCAA's ongoing investigation, and we will continue to cooperate with the NCAA as it works to complete its investigation." Multiple reports have linked Stalions to the purchase of tickets to games involving Michigan opponents, which he allegedly sent to collaborators who would record videos of the teams' signals. Stalions would then decode the signals by matching them to offensive and defensive plays, theoretically providing the Wolverines with an unbalanced advantage. The NCAA enforcement arm is expected to announce a decision on possible penalties at some point before the start of this season. Michigan has taken preemptive steps to mitigate the severity of any ruling, including by handing coach Sherrone Moore a two-game suspension this September. Moore was one of former coach Jim Harbaugh's top assistants when the sign-stealing endeavor was alleged to have occurred. At the time of Stalions' alleged appearance at the Michigan State game, CMU was coached by former Michigan offensive coordinator Jim McElwain. The Chippewas' quarterback coach at the time with Jake Kostner, who previously overlapped with Stalions as a student assistant with the Wolverines from 2015-18. Kostner resigned before the start of the 2024 season and McElwain retired at the end of the season.
USA Today
16 hours ago
- Sport
- USA Today
Central Michigan receives Notice of Allegations from NCAA for role in Michigan case
The Michigan advanced sign-stealing case continues to sprout further branches as things seemingly near a final response for the Wolverines. While we wait for that to occur (presumably somewhere before the start of the 2025 season), the NCAA has now turned its attention to Central Michigan. If you'll remember, while all of the news was breaking about former staffer Connor Stalions intricate, advanced sign-stealing operation, part of the evidence seemed to show Stalions in a Central Michigan coaching staff outfit, complete with recording glasses on the sidelines when the Chippewas took on Michigan State. James Bond, step aside. And while many Michigan fanboys seemed to throw water on Stalions actually being on the sidelines, that's come as close to being confirmed as it can be, and now the NCAA is going after Central Michigan. According to the dashboard of NCAA infractions, Central Michigan has been sent a Notice of Allegations for its role in the Michigan scandal. It should be noted that CMU has denied receiving a NOA from the NCAA (it's in the mail maybe), but if it's true, then the spider web of this thing just continues to expand. When the Cloak and Dagger situation first came to light, Central Michigan issued a statement acknowledging what was being reported and making the rounds on the internet. 'We are aware of inferences made in the new Netflix documentary regarding former University of Michigan football staff member Connor Stalions accessing the CMU sidelines during our opening game last September,' the statement read. 'For the past 10 months, CMU has fully cooperated with the NCAA's ongoing investigation, and we will continue to cooperate with the NCAA as it works to complete its investigation.' Shortly thereafter, the head coach at the time from the time the footage was taken, former Michigan Offensive Coordinator Jim McElwain, resigned. Read into that what you will. Another assistant coach at CMU who had a previous relationship with Stalions, Jake Costner, also stepped down. We'll continue to follow this developing story, especially if and when Central Michigan confirms receipt of the Notice of Allegations.
USA Today
a day ago
- Sport
- USA Today
Central Michigan served notice by NCAA around Connor Stalions sideline allegations
The long-running saga of Connor Stalions, the man at the center of a sign-stealing controversy at Michigan football, continues. The latest update in the story is centered around Central Michigan University and their game with Michigan State back in 2023 where Stalions appeared to be in disguise on their sideline recording plays and signals. On Tuesday, Tony Garcia of the Detroit Free Press reported that CMU has been served a notice of allegations from the NCAA related to the scandal. According to Garcia, the NOA (notice of allegations) was filed on June 27, and CMU will have a 90-day window to respond to the NCAA. While Central Michigan has denied knowledge of Stalions on the sideline, they did fire their QB coach at the time, who formerly worked with Stalions on the Michigan football staff. Contact/Follow us @The SpartansWire on X, and like our page on Facebook to follow ongoing coverage of Michigan state news, notes, and opinion. You can also follow Andrew Brewster on Twitter @IAmBrewster.
Yahoo
6 days ago
- Business
- Yahoo
EU pharma chief calls for European Nasdaq to boost biotech innovation
Stefan Oelrich, president of Bayer's pharmaceutical division and newly appointed head of the EU's pharmaceutical lobby EFPIA, pointed out the urgent need for capital market reform to support biotech development in Europe. 'We need the equivalent of a Nasdaq in Europe where we can raise capital for biotech. Because biotech is not just about government finance,' Oelrich said during a press conference last week. Launched in 1971, the Nasdaq (originally the National Association of Securities Dealers Automated Quotations) was the world's first electronic stock market. Known for its fully electronic trading model, the exchange has historically been attractive to fast-growing sectors, including life science, listing some of the world's largest tech companies, including Apple, Microsoft, and Google. Oelrich argued that Europe must urgently develop a similar equity-driven financing ecosystem. 'Today, there is very limited venture capital available, which is largely due to the way we manage equities. We invest our equities not in venture, but elsewhere,' he said. According to him, the lack of early-stage capital means European biotech innovations often migrate elsewhere — especially to the US, where funding and commercialisation opportunities are more robust. 'The transition from basic research to patented applications tends to follow where the capital is. We must ensure that innovation generated in European universities and research institutions stays in Europe,' he warned. 'Why don't we do it?' His remarks came just ahead of the unveiling of the EU's long-awaited Life Sciences Strategy, which aims to revive Europe's position as a hub for biotech research and development. The strategy acknowledges that the gap in venture capital investment is widening in Europe. It points to the continent's fragmented capital markets and heavy reliance on bank loans, which are often limited in volume and duration, as major structural issues. The strategy also recommends strengthening innovation hubs and integrating them into value chains to better attract private investment. However, it does not place significant emphasis on completing the EU's Capital Markets Union (CMU), a key demand from Oelrich. 'This may sound ambitious, but it's absolutely doable. Interestingly, everyone I talk to recognises the need: So why aren't we acting on it?' Oelrich asked. He also suggested that part of Europe's pension and life insurance capital could be redirected toward venture investment if appropriate political frameworks were put in place. 'Inventions can find a market here as it's not only about a lack of capital in Europe: It's about how we allocate it. We need to do a better job,' he concluded. The broader context The EU's Capital Markets Union remains incomplete, with progress hindered by regulatory divergence, inconsistent enforcement, and political resistance to deeper integration. While the CMU does not directly aim to create new stock exchanges, it does support efforts to expand access to capital, particularly for small and medium-sized enterprises (SMEs). This improved access could encourage the development of specialised or regional exchanges, though the broader goal remains integration rather than fragmentation. Currently, Europe lacks sector-specific stock exchanges. Major platforms like Euronext, the London Stock Exchange, Deutsche Börse, Nasdaq Nordic, and SIX Swiss Exchange list companies across a wide range of industries. Instead of dedicated exchanges, sector-focused investment is facilitated through indices such as the STOXX Europe 600 family, which tracks sectors like banking, automotive, and leisure. Still, for many in the biotech sector, the absence of a specialised capital-raising platform remains a barrier. Whether the EU will — and can — move to address this remains to be seen.
Yahoo
22-07-2025
- Business
- Yahoo
EU pharma chief calls for European Nasdaq to boost biotech innovation
Stefan Oelrich, president of Bayer's pharmaceutical division and newly appointed head of the EU's pharmaceutical lobby EFPIA, pointed out the urgent need for capital market reform to support biotech development in Europe. 'We need the equivalent of a Nasdaq in Europe where we can raise capital for biotech. Because biotech is not just about government finance,' Oelrich said during a press conference last week. Launched in 1971, the Nasdaq (originally the National Association of Securities Dealers Automated Quotations) was the world's first electronic stock market. Known for its fully electronic trading model, the exchange has historically been attractive to fast-growing sectors, including life science, listing some of the world's largest tech companies, including Apple, Microsoft, and Google. Oelrich argued that Europe must urgently develop a similar equity-driven financing ecosystem. 'Today, there is very limited venture capital available, which is largely due to the way we manage equities. We invest our equities not in venture, but elsewhere,' he said. According to him, the lack of early-stage capital means European biotech innovations often migrate elsewhere — especially to the US, where funding and commercialisation opportunities are more robust. 'The transition from basic research to patented applications tends to follow where the capital is. We must ensure that innovation generated in European universities and research institutions stays in Europe,' he warned. 'Why don't we do it?' His remarks came just ahead of the unveiling of the EU's long-awaited Life Sciences Strategy, which aims to revive Europe's position as a hub for biotech research and development. The strategy acknowledges that the gap in venture capital investment is widening in Europe. It points to the continent's fragmented capital markets and heavy reliance on bank loans, which are often limited in volume and duration, as major structural issues. The strategy also recommends strengthening innovation hubs and integrating them into value chains to better attract private investment. However, it does not place significant emphasis on completing the EU's Capital Markets Union (CMU), a key demand from Oelrich. 'This may sound ambitious, but it's absolutely doable. Interestingly, everyone I talk to recognises the need: So why aren't we acting on it?' Oelrich asked. He also suggested that part of Europe's pension and life insurance capital could be redirected toward venture investment if appropriate political frameworks were put in place. 'Inventions can find a market here as it's not only about a lack of capital in Europe: It's about how we allocate it. We need to do a better job,' he concluded. The broader context The EU's Capital Markets Union remains incomplete, with progress hindered by regulatory divergence, inconsistent enforcement, and political resistance to deeper integration. While the CMU does not directly aim to create new stock exchanges, it does support efforts to expand access to capital, particularly for small and medium-sized enterprises (SMEs). This improved access could encourage the development of specialised or regional exchanges, though the broader goal remains integration rather than fragmentation. Currently, Europe lacks sector-specific stock exchanges. Major platforms like Euronext, the London Stock Exchange, Deutsche Börse, Nasdaq Nordic, and SIX Swiss Exchange list companies across a wide range of industries. Instead of dedicated exchanges, sector-focused investment is facilitated through indices such as the STOXX Europe 600 family, which tracks sectors like banking, automotive, and leisure. Still, for many in the biotech sector, the absence of a specialised capital-raising platform remains a barrier. Whether the EU will — and can — move to address this remains to be seen. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
